{
  "success": true,
  "pagesUsed": [
    3,
    4,
    5,
    9,
    13,
    18,
    38,
    39,
    43,
    44,
    47,
    48,
    53,
    54,
    55
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Screening Window",
        "type": {
          "id": "3ad18c92-688e-4586-9f5e-9b47bb1df084",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "40ad771b-a6a0-4a76-929a-7a2a66d798a4",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "76074d33-1d21-4030-863a-021fae9702fe",
        "instanceType": "Timing",
        "windowLower": "-P28D",
        "windowUpper": "-P1D"
      },
      {
        "id": "timing_2",
        "name": "Cycle 1 Day 1 Window",
        "type": {
          "id": "2822ad56-7290-40f6-9b4e-4cfde2bbf0f1",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P3D",
        "valueLabel": "Day 3",
        "relativeToFrom": {
          "id": "fc19041d-3380-4a8a-b051-b79b53269756",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "ebc643f3-1578-4f03-97ab-caf17c7bdeec",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P3D"
      },
      {
        "id": "timing_3",
        "name": "Pembrolizumab Cycle Frequency",
        "type": {
          "id": "a7de1d1e-d26d-49c8-947f-2210969ef7ca",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P21D",
        "valueLabel": "Day 21",
        "relativeToFrom": {
          "id": "a20de127-de4b-44c4-8e4b-6d3f73d99a69",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "3123959c-f76c-4a26-a7d5-700dcc493f68",
        "instanceType": "Timing",
        "windowLower": "-P3D",
        "windowUpper": "P3D"
      },
      {
        "id": "timing_4",
        "name": "Paclitaxel Cycle Frequency",
        "type": {
          "id": "81039ad2-7c00-4267-8aaf-f8fe94c98196",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "29596099-b4cb-4b32-b194-4e77f8896a9e",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "7d56ad02-6668-4df4-9d1d-ecbebdbfc51c",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_5",
        "name": "Irinotecan Cycle Frequency",
        "type": {
          "id": "a5cfb00e-bed8-4e8c-a914-ffd98b37261a",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P14D",
        "valueLabel": "Day 14",
        "relativeToFrom": {
          "id": "b6d793cb-5c0e-44d5-af08-4c6ba9ac03f7",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "d7d483b0-3f4e-493b-ad45-d935cdf5d0f8",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_6",
        "name": "Adverse Event Monitoring",
        "type": {
          "id": "7f665d2b-b29a-4613-b4fc-a71279edb26d",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "P30D",
        "valueLabel": "Day 30",
        "relativeToFrom": {
          "id": "d01d01da-5681-4f25-ad41-81638ad00c64",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "68ceb3cb-f076-4219-a69a-42fbf9f51822",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P30D"
      },
      {
        "id": "timing_7",
        "name": "Serious Adverse Event Collection",
        "type": {
          "id": "6adbd7d8-5168-46d0-bc38-7e3c0231186d",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "P90D",
        "valueLabel": "Day 90",
        "relativeToFrom": {
          "id": "83a7d30e-9a0f-4d9a-aa38-dc6fd710d4bc",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "73906e30-7aa0-4321-aece-47920b26ba55",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P90D"
      },
      {
        "id": "timing_8",
        "name": "Contraception Period (Pembrolizumab)",
        "type": {
          "id": "fa907a24-69a0-4d28-be58-2242f00adf7c",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "P120D",
        "valueLabel": "Day 120",
        "relativeToFrom": {
          "id": "32b8f1ca-122e-40ec-b8ae-5e49916e33e0",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "b1ef90df-15c7-443a-a6f5-1ad6f69103a1",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P120D"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Complete Response (CR) Criteria",
        "instanceType": "Condition",
        "description": "Criteria to consider stopping treatment early",
        "text": "Attainment of investigator-determined confirmed complete response (CR) with at least 8 treatments received and 2 treatments beyond initial CR declaration."
      },
      {
        "id": "cond_2",
        "name": "Retreatment Eligibility",
        "instanceType": "Condition",
        "description": "Criteria for entering Second Course Phase",
        "text": "Radiographic disease progression after stopping for CR or 2 years of treatment, no interim cancer therapy, and meets safety parameters."
      },
      {
        "id": "cond_3",
        "name": "Infusion Reaction Grade 2",
        "instanceType": "Condition",
        "description": "Criteria for restarting or discontinuing after infusion reaction",
        "text": "If symptoms resolve within 1 hour, restart at 50% rate; if symptoms recur despite premedication, permanently discontinue."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Pembrolizumab Treatment Duration",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_treatment",
        "toElementId": "epoch_follow_up",
        "text": "Treatment may continue until 35 trial treatments (approx. 2 years) or disease progression/unacceptable toxicity."
      },
      {
        "id": "trans_2",
        "name": "Second Course Transition",
        "instanceType": "TransitionRule",
        "transitionType": "Rescue Therapy",
        "fromElementId": "epoch_follow_up",
        "toElementId": "epoch_second_course",
        "text": "Eligible subjects may receive up to 17 additional treatments (approx. 1 year) of pembrolizumab."
      },
      {
        "id": "trans_3",
        "name": "Immune-Related AE Modification",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Withhold or permanently discontinue pembrolizumab based on severity of irAEs per Table 3."
      },
      {
        "id": "trans_4",
        "name": "Pregnancy Discontinuation",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Immediate removal from study treatment upon confirmed pregnancy."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Confirmed Disease Progression",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Radiographic disease progression requires discontinuation of treatment unless Sponsor approves continuation."
      },
      {
        "id": "exit_2",
        "name": "Administrative/Safety Termination",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Inaccurate data recording, poor protocol adherence, or investigator/Sponsor decision."
      },
      {
        "id": "exit_3",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Last subject completes last study-related phone call or visit."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "CR Stopping Decision",
        "timepointId": "cycle_8_plus",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision to stop pembrolizumab after achieving confirmed CR.",
        "conditionIds": [
          "cond_1"
        ]
      },
      {
        "id": "dec_2",
        "name": "Retreatment Decision",
        "timepointId": "post_progression",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Investigator discretion to initiate Second Course Phase.",
        "conditionIds": [
          "cond_2"
        ]
      }
    ],
    "summary": {
      "timingCount": 8,
      "conditionCount": 3,
      "transitionRuleCount": 4,
      "exitCount": 3
    }
  }
}